Transradial approach tied to better bleeding and survival outcomes in STEMI with cardiogenic shock: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-05-09 04:00 GMT   |   Update On 2022-05-09 04:45 GMT
Advertisement

USA: Transradial access (TRA) in percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) with cardiogenic shock (CS) is tied to lower bleeding complications and mortality versus transfemoral access (TFA), says a recent study. The two treatments, however, were associated with similar TIMI3 (Thrombolytics in Myocardial Infarction) flow and procedural success rate. The study appears in European Heart Journal - Quality of Care and Clinical Outcomes.

Advertisement

Previous studies have shown that in STEMI, transradial access for PCI is associated with less bleeding and mortality than TFA. However, patients in cardiogenic shock are often given the treatment of TFA. Andrew M Goldsweig, Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, and colleagues, therefore, aimed to compare the safety and efficacy of TRA vs. TFA in cardiogenic shock in a meta-analysis.  

For this purpose, the researchers searched the online databases for studies comparing TRA to TFA in PCI for CS. Outcomes included in-hospital, 30-day and ≥ 1 year mortality, major and access site bleeding, procedural success, TIMI3 (Thrombolytics in Myocardial Infarction) flow, fluoroscopy time and contrast volume.

A total of six prospective and eight retrospective studies (TRA n = 8032, TFA n = 23 031) were identified. 

The study yielded the following findings:

  • TRA was associated with lower in-hospital (RR 0.59), 30-day and ≥ 1 year mortality, as well as less in-hospital major (RR 0.41) and access site bleeding (RR 0.42).
  • There were no statistically significant differences in post-PCI coronary flow grade, procedural success, fluoroscopy time, and contrast volume between TRA vs. TFA.

To conclude, In PCI for STEMI with cardiogenic shock, transradial access is associated with significantly lower mortality and bleeding complications than transfemoral access while achieving similar TIMI3 flow and procedural success rates.

Reference:

Muhammad Junaid Ahsan, Soban Ahmad, Azka Latif, Noman Lateef, Mohammad Zoraiz Ahsan, Waiel Abusnina, Sandeep Nathan, S Elissa Altin, Dhaval S Kolte, John C Messenger, Mark Tannenbaum, Andrew M Goldsweig, Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis, European Heart Journal - Quality of Care and Clinical Outcomes, 2022;, qcac018, https://doi.org/10.1093/ehjqcco/qcac018

Tags:    
Article Source : European Heart Journal - Quality of Care and Clinical Outcomes

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News